We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Analysis of Chromosome 7 Reveals Structures Linked to Diseases

By Biotechdaily staff writers
Posted on 16 Jul 2003
A team of researchers from six institutions has sequenced 99.4% of chromosome 7, which has led to the discovery of structural features that appear to promote disease-causing genetic changes. More...
The sequencing was reported in the July 10, 2003, issue of Nature.

Chromosome 7 is the largest chromosome sequenced to date. Previously, genome mapping techniques were developed on the chromosome, and it was the first chromosome to be searched by positional cloning in a successful hunt for the cystic fibrosis gene. During the current sequencing of the chromosome, researchers found that it contains an unusually high amount of duplicated sequence segments, and this duplication is much more extensive on the short arm of the chromosome. The reason for this remains unknown, although the researchers note that it may encourage the type of genetic deletions that cause disease.

This appears to be the case in Williams-Beuren syndrome, which is characterized by growth deficiency, heart disorders, and mild retardation. The syndrome is linked to very large deletions in a region of the long arm, which the new analysis shows to be a hotbed of duplicated segments. Such rearrangements of genetic material may occasionally help new genes to form, however. In all, about 1,150 protein-encoding genes were found on chromosome 7, about 20% less than predicted in a previous study by another team.

"Besides containing many genes that are crucial to development, this chromosome also hold the gene for cystic fibrosis and is frequently damaged in some types of leukemia and other cancers,” said Francis S. Collins, M.D., Ph.D., director of the US National Human Genome Research Institute (NHGRI, USA), which funded the study and also participated in the research. "This new analysis, coupled with our commitment to free and unrestricted access to sequence data, should further speed the discovery of genes on chromosome 7 related to human health and diseases.”




Related Links:
S National Human Genome Research Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.